Stavros Niarchos Foundation Cultural Center (SNFCC) (Kallithea)

Kleopatra Koutra

Stavros Niarchos Foundation Cultural Center (SNFCC) (Kallithea)
Legal Counsel

Kleopatra Koutra is Legal Counsel at Stavros Niarchos Foundation Cultural Center (SNFCC). Previously, she was Head of Legal Department at Agora Trading. She studied law at the University of Athens (LL.B) and obtained an LL.M specialised in Corporate and Commercial Law in 2006 from the University of London (University College London). Kleopatra previously worked at Spyridonos Law Firm. She is a qualified lawyer of the Athens Bar Association. Kleopatra speaks English, German, Italian and French and her research interest lies mainly in competition law, corporate law and intellectual property.

Articles

25654 Bulletin

Kleopatra Koutra The Hellenic Competition Authority rules that the decision of a dominant pharmaceutical firm to stop supplying the wholesalers and distribute the pharmaceuticals itself breaches the Competition Act but not Art. 82 EC despite the effect on trade between Member States (GlaxoSmithKline / Syfait)

8204

THE FACTS The dispute between GlaxoSmithKline (hereinafter “GSK”) and the Greek pharmaceutical wholesalers has its routes in 2000, when associations of the latter (amongst them “Sineterismos Farmakopion Etolias & Akarnanias”, “SYFAIT”) submitted numerous complaints to the Hellenic Competition (...)

Kleopatra Koutra The Cypriot Competition Authority rules that the incentive scheme offered to travel agents constitutes an abuse of its dominant position in violation of the national law (Helios Airways / Cyprus Airways)

4904

In 2004 Helios Airways Ltd (hereinafter “Helios”) submitted a complaint against Cyprus Airways Ltd (hereinafter “CA”) for abusing its dominant position in violation of section 4 and/or 6 of the Cypriot Law 207(?)/89 (“Law to Provide for the Control and Suppression of Restrictive Trade Agreements and (...)

Kleopatra Koutra, Stefanos Merikas The Greek Court of First Instance of Athens rejects the claim that a pharmaceutical company abused its dominant position by limiting the supply of certain drugs to the distributors in Greece in order to avoid parallel exports of its products (GlaxoSmithKline)

9531

The facts In 2001 a distributor of pharmaceutical products lodged a complain to the Court of First Instance of Athens against its supplier claiming that the latter’s decision to stop supplying it with drugs (as it had been doing for 20 years) and to establish a new distribution network in the (...)

Send a message